An Economic Evaluation of the Use of Granulocyte Colony-Stimulating Factor After Bone Marrow Transplantation in Children
被引:0
作者:
Nicholas Duncan
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Trust,Pharmacy Department
Nicholas Duncan
Margaret Hewetson
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Trust,Pharmacy Department
Margaret Hewetson
Ayad Atra
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Trust,Pharmacy Department
Ayad Atra
Gina Dick
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Trust,Pharmacy Department
Gina Dick
Ross Pinkerton
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Trust,Pharmacy Department
Ross Pinkerton
机构:
[1] Royal Marsden NHS Trust,Pharmacy Department
[2] Royal Marsden NHS Trust,Department of Paediatric Oncology
来源:
PharmacoEconomics
|
1997年
/
11卷
关键词:
Bone Marrow Transplantation;
Absolute Neutrophil Count;
Filgrastim;
Autologous Bone Marrow Transplantation;
Lenograstim;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Studies that have assessed the use of granulocyte colony-stimulating factor (G-CSF) following bone marrow transplantation have shown a significantly reduced time to neutrophil recovery with the use of this agent, which may translate into a reduced duration of antimicrobial therapy and hospitalisation.